ByrneWallace has made life sciences specialist Catherine Dowling a partner.

Ms Dowling trained with the firm and advises on private equity/venture capital, mergers and acquisitions, restructurings, and intellectual property.

She has worked with a broad range of entities in the life-sciences sector from early-stage university spin-out companies, to publicly quoted indigenous and global pharmaceutical, biotech, medical-device, and diagnostic organisations.

Vital role

Managing partner Feargal Brennan said: “We are delighted to welcome Catherine to the partnership.

"We recognise that our professionals play a vital role in ensuring we deliver an excellent service to our clients, and Catherine is now a highly experienced and respected practitioner in the sector.

“It is rewarding to see Catherine progress her career within ByrneWallace, from trainee solicitor to partner.”

Neil Keenan, head of corporate, said: “Our corporate practice has expanded significantly in recent years to become a market-leading Irish corporate and commercial practice. A key part of that growth has been driven by our focus on our key sectoral experience in life sciences and in other sectors, including technology, renewable energy, healthcare and the public sector.”